latest news on glp 1 drugs GLP-1 Drugs: 6 Things We've Learned About Their Effects Market Overview: GLP-1 Agonists and

doi: 10.1016/j.exger.2020.110888

The bottom line, according to Dr

When a product relies on fake social proof rather than real clinical data, it raises serious questions about legitimacy

Using products past their expiration dates wastes money on inactive ingredients

Common: Nausea

It must be determined that it meets at least two of the following three criteria: It has the potential to enhance or enhances sport performance It represents an actual or potential health risk to the athletes It violates the spirit of sport WADA also published: the 2024 Summary of Major Modifications and Explanatory Notes as compared to the 2023 List